Actis, Sequoia Pharmaceuticals Said to Plan Sale of Stake in Paras Pharmaceuticals Ltd. for Up to $700 Million
9/7/2010 8:16:22 AM
More...
|
Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
10/27/2008 8:52:57 AM
More...
|
Sequoia Pharmaceuticals Files Second IND for 2007 Novel Drug Enhances Pharmacokinetic Properties of Co- Administered Therapeutics
12/10/2007 7:23:20 AM
More...
|
Sequoia Pharmaceuticals Announces New CEO
10/29/2007 10:15:29 AM
More...
|
Sequoia Pharmaceuticals Raises $35 Million In Series C Financing
1/9/2007 8:09:30 AM
More...
|